How to Cite
Abstract
Secondary prevention of cervical cancer is the identification and treatment for preinvasive forms of the disease, which include cervical intraepithelial neoplasia (CIN). The traditional method of identification of CIN is cytological however the sensitivity and specificity of this method is limited. The efficacy of a test for human papillomavirus as well as new molecular-biological methods for assessing the prognosis of development of dysplasia and choice of appropriate treatment tactics are still in the process of discussion. The article contains information about different possibilities of using molecular-biological methods for assessing the prognosis of development of CIN and cervical cancer.References
Бахидзе Е.В. Фертильность, беременность и гинекологический рак. - СПб.: издательство «ДИЛЯ». - 2004. - 288 с.
Бахидзе Е.В., Аршавская И.Л. Роль вируса папилломы человека в диагностике, мониторинге и прогнозе рака шейки матки // Сиб. онкол. журнал. - 2012. - Т. 51. -№3. - С. 34-40.
Евстигнеева Л.А., Бахидзе Е.В., Семиглазов В.В. Роль генотипа вируса папилломы человека, множественности вируса, вирусной нагрузки и иммунного статуса в патогенезе рака шейки матки. Обзор литературы // Ученые записки. - Т. 15. - № 2. - 2008. -C. 10-14.
Кондриков Н.И., Шамаракова М.В., Горбачева Ю.В. Значение иммуногистохимического определения биомаркеров плоскоклеточных интраэпителиальных поражений шейки матки // Научно практический журнал акушерство и гинекология. - 2010. - № 6. - С. 44-48.
Шипицина Е.В., Оржесковская Е.А., Бабкина К.А. и др. Определение вирусной нагрузки и статуса ДНК вируса папилломы человека 16 типа методом ПЦР в реальном времени // Журнал акушерства и женских болезней. - 2004.- Т. LIII. - Вып. 4. - С. 26-32.
Aydogdu Е, Katchy A, Tsouko Е. et al. MicroRNA-regulat-ed gene networks during mammary cell differentiation are associated with breast cancer. Carcinogenesis - 2012. -Vol. 33. - P. 1502-1511.
Balch C, Naegeli K, Nam S. et al. A unique histone deacetylase inhibitor alters microRNA expression and signal transduction in chemoresistant ovarian cancer cells. Cancer Biol Ther - 2012. - Vol. 13. - P. 681-693.
Bosch FX, de Sanjose S Chapter 1: Human papillomavirus and cervical cancer - burden and assessment of causality // J Natl Cancer Inst Monogr. - 2003. - Vol. 3 - P. 13.
Bosch FX, de Sanjose. The epidemiology of human papillomavirus infection and cervical cancer // Dis Markers 2007. - Vol. 23. - P. 213-227.
Castellsague X, Bosch FX, Munoz N Environmental co-factors in HPV carcinogenesis // Virus Res. -2002. Vol. 89. - P. 191-199.
Cho WC: MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy // Int J Biochem Cell Biol. - 2010. - Vol. 42. - P. 1273-1281.
Dillner J., Rebolj M., Birembaut P. et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study // BMJ. - 2008 Oct. - Vol. 13. - P. 337:a1754.
Farazi TA, Hoell JI, Morozov P and Tuschl T: MicroRNAs in human cancer // Adv Exp Med Biol. - 2013. - Vol. 774. - P. 1-20.
FIGO IFoGaO (2009) Global Guidance For Cervical Cancer Prevention and Control.
Fontaine J, Hankins C, Money D et al. Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV // J Clin Virol. - 2008. - Vol. 43. - P. 307-312.
Garzon R, Fabbri M, Cimmino A. et al. MicroRNA expression and function in cancer // Trends Mol Med. - 2006. - Vol. 12. - P. 580-587.
Gocze K, Gombos K, Kovacs K. et al.MicroRNA expressions in HPV-induced cervical dysplasia and cancer // Anticancer Res. - 2015 Jan. - Vol. 35 (1). - P. 523-530.
Hawes SE, Kiviat NB Are genital infections and inflammation cofactors in the pathogenesis of invasive cervical cancer? // J Natl Cancer Inst. - 2002. - Vol. 94. - P. 1592-1593.
Huh WK Human papillomavirus infection: a concise review of natural history // Obstet Gynecol. - 2009. - Vol. 114. - P. 139-143.
Juneja A, Sehgal A, Mitra AB, Pandey A.A survey on risk factors associated with cervical cancer // Indian J Cancer. - 2003. - Vol. 40. - P. 15-22.
Kalantari M, Blennow E, Hagmar B, Johansson B. Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas // Diagn Mol Pathol. - 2001. - Vol. 10. - P. 46-54.
Klaes R., Benner A., Friedrich T. et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia // Am. J. Surg. Pathol. - 2002. - Vol. 26. - Р 1389-1399.
Koshiol J, Lindsay L, Pimenta JM. et al. (2008) Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis // Am J Epidemiol. - 2008. - Vol. 168. - P 123-137.
Lorincz AT, Castle PE, Sherman ME. et al. Viral load of human papillomavirus and risk of CIN3 or cervical cancer // Lancet. - 2002. - Vol. 360. - P. 228-229.
Li B, Hu Y, Ye F. et al. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection // Int J Gynecol Cancer. -2010 May. - Vol. 20 (4). - P. 597-604.
Lu J, Getz G, Miska EA. et al. MicroRNA expression profiles classify human cancers // Nature. - 2005. - Vol. 435. - P 834-838.
Mazarico E, Gómez-Roig MD, Miñano J. et al. Relationship of human papilloma virus multiple genotype infection with patient>s age and type of cervical lesion // Eur J Gynaecol Oncol. - 2014. - Vol. 35 (4). - P 378-381.
Monsonego J., Cox J.T., Behrens C. et al. Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial // Gynecol. Oncol. - 2015. - Vol. 137. - N. 1. -P. 47-54.
Peitsaro P., Johansson B., Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique // J. Clin. Microbiol. - 2002. -Vol. 40. - P. 886-891.
Pritchard CC, Kroh E, Wood B. et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies // Cancer Prev Res (Phila). -2012. - Vol. 5. - P. 492-497.
Rijkaart D.C., Berkhof J., Rozendaal L. et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial // Lancet Oncol. - 2012 Jan. - Vol. 13 (1). - P. 78-88.
Rolon P.A., Smith J.S., Munoz N. et al. Human papillomavirus infection and invasive cervical cancer in Paraguay // Int. J. Cancer. - 2000. - Vol. 85. - P 486-491.
Sasieni P.D., Cuzick J., Lynch-Farmery E. et al. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer // Bridsh Journal of Cancer. - 1996. - Vol. 73. - P 1001-1005.
Schiffman M, Castle PE, Jeronimo J. et al. Human papillomavirus and cervical cancer // Lancet. - 2007. - Vol. 370. - P. 890-907.
Seraceni S, De Seta F, Colli C et al. High prevalence of hpv multiple genotypes in women with persistent chlamydia trachomatis infection // Infect Agent Cancer. - 2014 Sep. - Vol. 8. - P. 9-30.
Snijders P.J., Steenbergen R.D.M., Heideman D.A. et al. HPV-mediated cervical carcinogenesis: concepts and clinical implications // J. Pathol. - 2006. - Vol. 208. - Р 152-164.
Spinillo A1, Gardella B, Roccio M et al. Multiple human papillomavirus infection with or without type 16 and risk of cervical intraepithelial neoplasia among women with cervical cytological abnormalities // Cancer Causes Control. - 2014 Dec. - Vol. 25 (12). - P 1669-1676.
Stanley MA. Human papillomavirus and cervical carcinogenesis // Best Pract Res Clin Obstet Gynaecol. - 2001. - Vol. 15. - P 663-676.
Stanley MA Immune responses to human papilloma viruses // Indian J Med Res. - 2009. - Vol. 130. - P. 266-276.
Tian Q, Li Y, Wang F, Li et al. MicroRNA detection in cervical exfoliated cells as a triage for human papillomavirus-positive women// J Natl Cancer Inst. - 2014 Sep. - Vol. 106 (9).
Abraham Pedroza-Torres , Eduardo López-Urrutia, Verónica García-Castillo et al. MicroRNAs in Cervical Cancer: Evidences for a miRNA Profile Deregulated by HPV and Its Impact on Radio-Resistance // Molecules. - 2014. - Vol. 19 (5). - P 6263-6281.
Tungteakkhum S.S., Duerksen- Hughes P.J. Cellular binding partners of the human papillomavirus E6 protein // Arch.Virol. - 2008. - Vol.153. - N3. - P397-408.
Yoshida T, Sano T, Kanuma T et al.Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions // Int J Gynecol Cancer. - 2008 Jan -Feb. - Vol. 18 (1). - P. 121-127.
Zhu XL, Wen SY, Ai ZH et al. Screening for characteristic microRNAs between pre-invasive and invasive stages of cervical cancer// Mol Med Rep. - 2015 Jul. - Vol. 12 (1). - P 55-62.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...